纵横研报
Ticker Detail

600713.SHG

¥5.41+0.56% 南京医药 Drug Manufacturers - General
00Reports China 医疗健康
NanJing Pharmaceutical Co Ltd
医疗健康 · 综合制药

Nanjing Pharmaceutical Group Company Limited engages in the distribution of pharmaceuticals, medical devices, and health products in China. It also involved in the wholesale and retail of pharmaceuticals; provision of internet + Chinese medicine pharmacy service platform; and pharmaceutical third-party logistics services. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.

MARKET 市值 6.66B CNY PE 12.4x Fwd 129.9x 52W ¥4.65 – ¥6.65 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 3.08 营收 YoY -2.8% ROE 10.1% 营业利润率 2.8% 净利润率 1.1%
ANALYST 股息率 3.37%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制